| Drugs with this side effect
			
	        	2-hydroxysuccinaldehyde: postmarketing 
				4-PBA: common 
				4-methylpyrazole
				5-ASA: postmarketing 
				5-FU
				5-aminolevulinic acid
				5-aza-2'-deoxycytidine: 22% - 81.9% 
				5-azacytidine: very common, 2.3% - 69.5% 
				5-fluorocytosine
				6-mercaptopurine
				68Ga
				A77 1726
				APAs
				Anidulafungin: 7.31% - 16% 
				BCNU: 1-10% 
				BPTI
				Benicar-HCT
				Bivalirudin: postmarketing 
				CAS 76095-16-4
				CAS 76420-72-9
				CGP 19835A: very common 
				Cancidas: uncommon, 0% - 11% 
				Carfilzomib: 1.33% - 46.8% 
				D-penicillamine
				EDTA
				FAMP
				FK463: 2.5% - 51.2% 
				FdUrd
				Fe(III
				Forteo
				Ge-132: 2% 
				Glat copolymer: infrequent 
				Goserelin: 0% - 1-10% 
				Histrelin
				ICI 182,780: 4.5% - 5% 
				K779: postmarketing, 0% - 35% 
				L-Dmp: infrequent 
				LMWH: 0% - 16% 
				LY146032: postmarketing, common, 2.1% - 15.5% 
				Leuprorelin: 5% 
				Lisinopril: very rare, postmarketing 
				Meropenem anhydrous: 5.5% 
				N-carbamylglutamate
				NSC 352122
				Nuvocid
				Octreotide
				PCI-32765
				PGE1
				Photofrin: 28% - 32% 
				Photofrin II
				Promacta
				Refludan: 1.1% - 13.1% 
				Revasc: 0.676% - 6.39% 
				Romidepsin: 2.94% - 72.3% 
				SOM230: 4% 
				SU5416
				Signifor: 4% 
				TMC435: 11% 
				TR-700
				Triptorelin: 1.4% 
				UDCA: postmarketing 
				VACV: 0% - 12% 
				Vancocine
				ZnCl2
				abacavir
				abacavir-lamivudine: uncommon 
				abiraterone
				acamprosate: infrequent 
				acetaminophen: 2.7% 
				acetohydroxamic acid
				actinomycin D
				acyclovir: very rare 
				adefovir dipivoxil
				alendronate
				aliskiren
				allopurinol: postmarketing 
				alpha-methyl-p-tyrosine
				alvimopan
				ambrisentan: postmarketing 
				amikacin
				aminoglutethimide
				amoxicillin: postmarketing 
				amphotericin B: 26.7% - 47.9% 
				ampicillin
				amsacrine: 1-10% 
				anagrelide: 1-5% 
				anastrozole: 3.65% - 5.14% 
				anthracycline
				apixaban: common, 2.58% - 3.01% 
				aprepitant: 0% - 4.3% 
				aripiprazole
				arsenic
				arsenic trioxide: common 
				asenapine
				aspirin
				atorvastatin
				atovaquone: 0% - 9% 
				auranofin: postmarketing, 1.6% - 3.1% 
				axitinib: 4% 
				azathioprine: uncommon 
				azithromycin
				aztreonam
				baclofen
				balsalazide: 3.7% 
				belinostat: 11% - 32% 
				bendamustine: 19% 
				betaxolol
				bexarotene: 5.95% - 24.5% 
				bezafibrate: 1.1% 
				bicalutamide: 7% 
				bleomycin hydrochloride
				boceprevir: very common, 20% - 30% 
				bortezomib: 0% - 37% 
				bosentan: postmarketing, common, 8% 
				bosutinib: 12.3% - 27.4% 
				bromcresol green
				budesonide
				bupivacaine: 8.17% - 12% 
				bupropion: postmarketing, rare 
				busulfan
				cabazitaxel: 5% - 97.3% 
				candesartan: postmarketing 
				candesartan cilexetil
				capecitabine: 1% - 83% 
				captopril
				carbamazepine: very rare 
				carbenicillin
				carbidopa
				carboplatin: 71% - 90% 
				carnitine: 3% - 12% 
				carvedilol: 2% - 2.4% 
				cefazolin: postmarketing 
				cefepime: postmarketing 
				cefoxitin
				cefpodoxime
				ceftaroline
				ceftizoxime
				ceftobiprole
				ceftriaxone: 0.1 - 1.0% 
				celecoxib
				cerivastatin
				cevimeline
				chlorambucil
				cidofovir: postmarketing, 24.3% 
				cilazapril
				cilostazol
				cinacalcet: 5.88% - 17.2% 
				ciprofloxacin: postmarketing, rare 
				cisplatin
				citalopram: postmarketing, infrequent, uncommon 
				cladribine: very common, 1% 
				clarithromycin
				clindamycin
				clobazam: postmarketing 
				clodronate
				clofarabine: 75.4% - 83.3% 
				clofazimine
				clomipramine: 2% 
				clonazepam
				clopidogrel: very rare, postmarketing 
				clozapine
				colchicine: postmarketing 
				colestyramine
				conivaptan
				copolymer 1
				copper
				crizotinib
				cyclophosphamide
				cyproterone
				cyproterone acetate
				cysteamine
				cytarabine: 1% - 18.2% 
				d-telaprevir: 17% 
				dabigatran etexilate
				dabrafenib: 0% - 55% 
				dalbavancin
				dalteparin: 0% - 1.34% 
				dantrolene
				darunavir
				dasatinib: 3% - 75% 
				deferasirox: postmarketing 
				degarelix
				delamanid
				delavirdine
				deprenyl: infrequent, 0% 
				dexmedetomidine: postmarketing, 2% - 3% 
				dexrazoxane
				diatrizoate
				diazepam
				diclofenac: very rare 
				dicloxacillin
				didanosine: postmarketing 
				dipyridamole
				docetaxel: 1% - 96.8% 
				dolasetron
				donepezil: infrequent, frequent 
				doripenem: 1% - 10% 
				doxepin: infrequent 
				doxercalciferol
				doxorubicin: uncommon, very common, 0% - 72.2% 
				doxycycline
				duloxetine: infrequent 
				efavirenz
				eletriptan: rare 
				eltrombopag
				emtricitabine: postmarketing, uncommon, 7% - 9.5% 
				eplerenone
				eribulin: 2% - 58% 
				ertapenem: 5.7% - 6.9% 
				eslicarbazepine acetate
				esomeprazole magnesium
				estramustine phosphate
				etidronate
				etodolac
				etoposide: 0 to 33 - 72% 
				etoposide phosphate
				etoricoxib
				etravirine
				everolimus: common, very common, 0% - 61% 
				ezetimibe
				famciclovir: 0.1% 
				famotidine
				febuxostat
				felbamate
				felodipine
				fenofibrate: postmarketing 
				fenofibric acid: postmarketing 
				fentanyl: common, 9.09% - 31.6% 
				fidaxomicin: 2% - 2.48% 
				flucloxacillin
				fluconazole
				fludarabine
				fluoxetine: infrequent 
				flurbiprofen
				flutamide
				fluvoxamine: rare, infrequent 
				fondaparinux: uncommon, common, 0.272% - 19.6% 
				fosaprepitant
				fosaprepitant dimeglumine: 0% - 4.3% 
				foscarnet: 0.14% - 15% 
				fosinopril
				fosinoprilat
				fosphenytoin: infrequent 
				fotemustine
				furosemide
				fusidic acid
				gabapentin: postmarketing, infrequent 
				gadobenate dimeglumine
				galantamine: 3% 
				ganciclovir: 16.8% - 19.7% 
				gefitinib
				gemcitabine: very common, 0% - 86% 
				gemfibrozil
				gemifloxacin
				gentamicin
				glibenclamide
				gliclazide
				glimepiride
				granisetron: 4% - 9.4% 
				guanidinium
				haloperidol
				hetastarch: postmarketing 
				hexamethylmelamine
				histamine
				hydralazine: uncommon 
				hydrochlorothiazide
				hydroxybutyrate
				hydroxychloroquine
				hydroxyurea: common 
				ibandronate
				ibuprofen: 2.3% - 16.7% 
				icodextrin
				idarubicin
				ifosfamide
				iloperidone
				imatinib: postmarketing, very common, 0% - 42% 
				indacaterol
				indapamide: postmarketing 
				indinavir: 0.6% - 2.1% 
				indomethacin
				iodide
				irbesartan: rare 
				irbesartan-hydrochlorothiazide
				irinotecan: 2.1% - 98.6% 
				isosorbide-5-mononitrate
				isradipine
				ivermectin
				ixabepilone: 1% - 8% 
				ketoprofen
				ketorolac
				ketorolac tromethamine
				lacosamide
				lamivudine: postmarketing, uncommon, 1% - 4% 
				lamotrigine: rare, infrequent 
				lanreotide: 3.45% - 14.8% 
				lansoprazole
				lapatinib: 0% - 10% 
				lasofoxifene: uncommon 
				leflunomide: uncommon 
				lenalidomide: postmarketing, common, 6.1% - 31.4% 
				lercanidipine: uncommon 
				leuprorelin acetate
				levodopa/carbidopa
				levonorgestrel
				linezolid: postmarketing, 0% - 7.1% 
				lithium carbonate
				lomefloxacin
				lomitapide
				losartan: postmarketing, 14% 
				lurasidone: infrequent 
				mTHPC: common 
				macitentan: 13% 
				maraviroc
				medroxyprogesterone: postmarketing 
				medroxyprogesterone acetate: postmarketing 
				mefenamic acid
				megestrol: 0% - 5% 
				meloxicam: 0% - 4.1% 
				melphalan: very common 
				memantine: frequent 
				mephenytoin
				meropenem: 5.5% 
				mesna
				methotrexate
				methylphenidate: very rare, postmarketing 
				metolazone
				mianserin
				miconazole: 1.7% - 2.8% 
				mirtazapine: postmarketing, rare 
				misoprostol: postmarketing 
				mitomycin C
				mitotane
				mitoxantrone: 6% - 5-75% 
				modafinil
				morphine: 2% 
				moxifloxacin
				mycophenolate mofetil: 3.4% - 53% 
				mycophenolic acid: 21.6% - 53% 
				nabilone
				nabumetone: postmarketing, 0.5% 
				naproxen
				naratriptan: rare 
				nefazodone: infrequent 
				nelarabine: 10% - 99% 
				nelfinavir: 0% - 2.56% 
				nevirapine: postmarketing, uncommon, 7% - 7.3% 
				nifedipine
				nilotinib: common, 4% - 27% 
				nilutamide
				nimodipine
				nisoldipine
				nitazoxanide
				nitrofurantoin
				nizatidine
				ofatumumab: 5% - 17% 
				ofloxacin: postmarketing 
				olanzapine: infrequent 
				olmesartan
				olsalazine
				omeprazole: postmarketing 
				oseltamivir
				oxaliplatin: very common, 0.1% - 85.2% 
				oxaprozin
				oxycodone
				paclitaxel: uncommon, very common, 4% - 97% 
				paliperidone
				palonosetron
				pamidronate: postmarketing, common, 0% - 47.8% 
				pantoprazole: rare 
				paricalcitol
				paroxetine: infrequent, uncommon 
				pazopanib
				pemetrexed: 0% - 33% 
				penciclovir: 0.1% 
				pentamidine
				pentastarch
				pentosan polysulfate
				pentostatin: 5% - 35% 
				pentoxifylline
				pergolide: frequent, 1.1% 
				perindopril
				perindopril erbumine: postmarketing 
				perindoprilat: postmarketing 
				phenylbutyric acid: 9% 
				phenytoin: infrequent 
				pimozide: postmarketing 
				pioglitazone
				piperacillin
				piroxicam
				pixantrone
				pomalidomide: 20.5% - 45.7% 
				ponatinib: 9% - 55% 
				posaconazole: 1.91% - 14.2% 
				pralatrexate
				pramipexole
				prasugrel
				pravastatin: postmarketing 
				prednisone
				pregabalin: infrequent 
				primidone
				probenecid
				procarbazine
				progesterone
				propafenone: postmarketing 
				prostacyclin: postmarketing 
				quetiapine: infrequent 
				rabeprazole
				radium: 2% - 93% 
				raltegravir
				raltitrexed: 12-19% 
				ranitidine
				rapamycin: very common, 21% - 37% 
				rasagiline
				rasburicase
				reboxetine
				regorafenib: 79% 
				remifentanil: 0% - 2.84% 
				retinoic acid: postmarketing 
				ribavirin: common, very common, 0.6-0.8% - 35% 
				rifabutin: 6% 
				rifampicin
				rifapentine
				rifaximin: 7.86% 
				riluzole: infrequent 
				riociguat: 7% 
				risedronate
				risperidone: infrequent, 0.1% - 1% 
				ritonavir: 4% 
				rivaroxaban
				rivastigmine: frequent 
				ropinirole: infrequent, 2% 
				ropivacaine: 0.2% - 13.8% 
				rosiglitazone: common, 7.1% 
				rufinamide: frequent 
				ruxolitinib: very common, 11% - 96.1% 
				salmon calcitonin acetate
				samarium
				saquinavir: common 
				sertraline: rare 
				sibutramine
				sildenafil
				simvastatin: postmarketing 
				sitaxsentan: uncommon 
				sodium cromoglycate
				sodium ferric gluconate
				sofosbuvir: common, very common, 0% - 21% 
				sorafenib: postmarketing, common 
				stavudine: postmarketing, rare 
				streptozotocin
				sulfasalazine
				sulindac
				sumatriptan: rare 
				sunitinib: 2% 
				tacrolimus: common, 1% - 50% 
				tamoxifen: 3.65% - 5.14% 
				telavancin: uncommon 
				telithromycin
				telmisartan: postmarketing, rare, uncommon 
				temozolomide: uncommon, common, 1% - 2% 
				temsirolimus
				teniposide: 88% 
				tenofovir disoproxil fumarate
				tenoxicam
				terbinafine: postmarketing 
				testosterone: postmarketing, 2.47% - 2.5% 
				thalidomide: 0% - 14.5% 
				thioridazine: postmarketing 
				thiotepa
				tiagabine: infrequent 
				tiaprofenic acid
				tigecycline: 4.2% - 6% 
				tiopronin
				tipranavir: uncommon, 0% - 2.3% 
				tizanidine: infrequent 
				tobramycin
				tofacitinib
				tolcapone: infrequent 
				topiramate: frequent, 0.8% - 3% 
				topotecan: very common, 1.9% - 98% 
				trabectedin
				tramadol: postmarketing, uncommon 
				trametinib: 0% - 55% 
				trandolapril
				tranexamic acid: 5.6% 
				tranylcypromine
				trazodone
				treprostinil
				trimetrexate: 0% - 15.3% 
				troglitazone: postmarketing 
				trovafloxacin
				v 1784: postmarketing, uncommon, common 
				valdecoxib
				valganciclovir: 8% - 26% 
				valproate: postmarketing 
				valrubicin
				varenicline: infrequent 
				venlafaxine: infrequent 
				verteporfin
				vigabatrin: common 
				vinblastine
				vincristine: 16.9% - 34% 
				vinflunine
				vinorelbine: 1% - 87% 
				vitamin D2
				vorapaxar: 5% 
				voriconazole: common, 0% - 2.7% 
				vorinostat
				warfarin
				zalcitabine
				zaleplon: infrequent 
				zidovudine: common, 1% - 2% 
				zidovudine/lamivudine
				ziprasidone: infrequent 
				zoledronic acid: postmarketing, common, 4.4% - 22% 
				zolpidem: rare 
				zonisamide: infrequent 
				zopiclone: infrequent 
				 | Drugs with this indication |